CapitalBio® BioelectronSeq 4000 Sequencer
2Pages

Clinical Application Chromosomal disease detection Chromosome Aneuploid Noninvasive Prenatal Genetic Testing Chromosome Microdeletion /Microduplications Non-invasive Prenatal Genetic Testing Chromosomal Abnormalities Detection Preimplantation Genetic Screening and Diagnosis (PGS / PGD) Genetic Disease Genetic Testing Hereditary Deafness Panel Duchenne / Behrens Muscular Dystrophy (DMD / BMD) Panel 17 Common Inherited Disease Panel 3,500 Single Gene Disease Panel Exome Panel High-throughput sequencing system for independent use in clinical laboratories Tumor-related Gene Testing Hereditary Breast / Ovarian Cancer Panel 18 Inherited Cancer Panel Human Papillomavirus (HPV) Genotyping Test Tumor Individualized Chemotherapeutic Drug Genetic Test Lung Cancer Individualized Targeted Drug Detection Tumor Specific Targeted Drug Detection (50 Genes) Tumor Specific Targeted Drug Detection (409 Genes) Microbial Genetic Testing Intestinal Flora Detection Order Information Product Data Analysis & Management Software for Noninvasive Prenatal Testing Building C, 88 Kechuang 6th Street, Yizhuang Biomedical Park Beijing Economic-Technological Development Area Beijing 101111 China Preinstalled in BioelectronSeq 4000 System Tel: +86-10-69002900 Fax: +86-10-69002988 Email: globalsales@capitalbiotech.com Website : http://www.capitalbiotech.com CapitalBio Technology CapitalBio Genomics

CapitalBio® BlatipaC TPIN ®oi BioelectronSeq 4000 Sequencer CapitalBio® BioelectronSeq 4000 Sequencer Specications for BioelectronSeq 4000 Sequencer CapitalBio BioelectronSeq 4000 System is a next generation sequencing system developed and produced Semiconductor Sequencing Technology. Working with clinical testing kits and automated data analysis & Working environment Temperature: 68 –77° F (20 –25° C); Humidity: 40–60%, noncondensing; Altitude: <6,500 ft (2,000 m) by CapitalBio Corporation in collaboration with Thermo Fisher Scientific Inc. in China. The system adopts management software,...